Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.
Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. The probability of stroke recurrence is high: about 25% the first year , and 30 to 40% in the 5 years following the stroke. Recurrent strokes are responsible for significant disability, institutionalization, major neurocognitive disorders, and death. In order to reduce the risk of stroke recurrence, multiple secondary prevention strategies have demonstrated their effectiveness, such as the prescription of drugs (in particular statins and antithrombotics), the establishment of a balanced diet, the practice of an activity physical, or even tobacco addiction. However, the effectiveness of these strategies is optimal if and only if patients adhere to them. In addition, previous studies have focused on the brakes and levers of medication adherence in the context of secondary prevention treatment in stroke. In elderly patients, other obstacles could have been identified by specific studies, such as cognitive, sensory, functional disorders or even isolation.
Study Type
OBSERVATIONAL
Enrollment
30
recorded semi-structured interviews between the patients and the pharmacist
institute of aging - Hôpital des Charpennes
Villeurbanne, France
RECRUITINGAnalysis of the verbatim from the transcription of the recorded interviews.
Describing the content of discussions, relating to antithrombotic treatment for secondary prevention, between elderly patients previously treated with antithrombotics and admitted to hospital for an ischemic stroke and a pharmacist
Time frame: one year
Analysis of verbatim statements from the transcription of recorded interviews on patients' representations and beliefs regarding antithrombotics
Exploring patients' representations and beliefs regarding antithrombotics before and after the onset of stroke or recurrence of stroke
Time frame: 15 to 60 minutes per patient
Analysis of verbatim statements from the transcription of recorded interviews on patients' medication adherence to antithrombotics
Explore patients' medication adherence to antithrombotics before the onset of stroke or recurrence of stroke
Time frame: 15 to 60 minutes per patient
Analysis of verbatim statements from the transcription of recorded interviews on the impact of the occurrence of stroke or recurrence of stroke on medication adherence
Explore the impact of stroke occurrence or stroke recurrence on patient medication adherence (including motivation, ambivalence, confidence in medication benefits)
Time frame: 15 to 60 minutes per patient
Analysis of verbatim statements from the transcription of recorded interviews on the obstacles and levers to medication adherence
Identify the barriers and levers to drug adherence with antithrombotics
Time frame: 15 to 60 minutes per patient
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.